SCHEMBL30946271

SCHEMBL30946271

O=c1ccc2c(Cl)cccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.53
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
CA1 P00915 1/20 0.47
CA3 P07451 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CA5B Q9Y2D0 1/20 0.47
PDE3B Q13370 6/20 0.44
PDE3A Q14432 6/20 0.44
DYRK1A Q13627 1/20 0.43
CYP1A2 P05177 2/20 0.42
TNKS2 Q9H2K2 2/20 0.42
CYP2C19 P33261 1/20 0.42
NOS1 P29475 1/20 0.42
CYP2A6 P11509 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1081802 1.00 DAO (0.53) DAOCA12CA9CA1CA3
SCHEMBL10285341 0.77 CA12 (0.48) CA12CA9CA1CA3CA4
SCHEMBL2957821 0.75 F11 (0.46) CA12CA9CA1CA3CA4
SCHEMBL332886 0.75 TDP1 (0.50) CA12CA9CA1CA3CA4
SCHEMBL3874061 0.75 KDM4E (0.60) DAOCA12CA9CA1CA3
SCHEMBL709815 0.75 PDE3B (0.52) CA12CA9CA1CA3CA4
SCHEMBL31169726 0.75 CYP1A2 (0.62) CA12CA9CYP1A2TNKS2CYP2C19
SCHEMBL2084671 0.75 CYP1A2 (0.62) CA12CA9CYP1A2TNKS2CYP2C19
SCHEMBL1082903 0.75 DAO (0.53) DAOCA12CA9CA1CA3
SCHEMBL433885 0.75 TNKS2 (0.62) DAOCA12CA9CA1CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583874-A1 MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) 2025-07-16 EP disclosed
WO-2024132001-A1 MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) 2024-06-27 WO disclosed